Cargando…

Antibody-dependent SARS coronavirus infection is mediated by antibodies against spike proteins

The severe acute respiratory syndrome coronavirus (SARS-CoV) still carries the potential for reemergence, therefore efforts are being made to create a vaccine as a prophylactic strategy for control and prevention. Antibody-dependent enhancement (ADE) is a mechanism through which dengue viruses, feli...

Descripción completa

Detalles Bibliográficos
Autores principales:	Wang, Sheng-Fan, Tseng, Sung-Pin, Yen, Chia-Hung, Yang, Jyh-Yuan, Tsao, Ching-Han, Shen, Chun-Wei, Chen, Kuan-Hsuan, Liu, Fu-Tong, Liu, Wu-Tse, Chen, Yi-Ming Arthur, Huang, Jason C.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier Inc. 2014
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7092860/ https://www.ncbi.nlm.nih.gov/pubmed/25073113 http://dx.doi.org/10.1016/j.bbrc.2014.07.090

Ejemplares similares

SARS coronavirus has antibody-dependent enhancement (ADE) effect through the autologous antibodies against envelope spikes on Fcγ receptor expressing cells
por: Yeh, Chun-Sheng, et al.
Publicado: (2016)

Stabilized coronavirus spike stem elicits a broadly protective antibody
por: Hsieh, Ching-Lin, et al.
Publicado: (2021)

Antibody detection of SARS-CoV spike and nucleocapsid protein
por: Chang, Mau-Sun, et al.
Publicado: (2004)

Factors influencing neutralizing antibody titers elicited by coronavirus disease 2019 vaccines
por: Kung, Yu-An, et al.
Publicado: (2023)

Purified coronavirus spike protein nanoparticles induce coronavirus neutralizing antibodies in mice
por: Coleman, Christopher M., et al.
Publicado: (2014)

Monoclonal antibody targeting the conserved region of the SARS-CoV-2 spike protein to overcome viral variants
por: Wu, Wan-Ling, et al.
Publicado: (2022)

Characterization of novel monoclonal antibodies against MERS-coronavirus spike protein
por: Goo, Junghyun, et al.
Publicado: (2020)

Development of an Indirect ELISA Based on Spike Protein to Detect Antibodies against Feline Coronavirus
por: Dong, Bo, et al.
Publicado: (2021)

Characterization of neutralizing monoclonal antibodies recognizing a 15-residues epitope on the spike protein HR2 region of severe acute respiratory syndrome coronavirus (SARS-CoV)
por: Lai, Szu-Chia, et al.
Publicado: (2005)

SARS coronavirus spike polypeptide DNA vaccine priming with recombinant spike polypeptide from Escherichia coli as booster induces high titer of neutralizing antibody against SARS coronavirus
por: Woo, Patrick C.Y., et al.
Publicado: (2005)

Modeling and Manipulating Antibody Response Against Influenza and Coronavirus Spike Proteins and Exploring their Role in Directing Spike Evolution
por: Amitai, Assaf, et al.
Publicado: (2021)

Anti-Spike Antibody Response to Natural Infection with SARS-CoV-2 and Its Activity against Emerging Variants
por: Chen, Cheng-Pin, et al.
Publicado: (2022)

Characterization of Niemann-Pick Type C2 Protein Expression in Multiple Cancers Using a Novel NPC2 Monoclonal Antibody
por: Liao, Yi-Jen, et al.
Publicado: (2013)

Viral surface geometry shapes influenza and coronavirus spike evolution through antibody pressure
por: Amitai, Assaf
Publicado: (2020)

The rapid diagnosis and effective inhibition of coronavirus using spike antibody attached gold nanoparticles
por: Pramanik, Avijit, et al.
Publicado: (2021)

Viral surface geometry shapes influenza and coronavirus spike evolution through antibody pressure
por: Amitai, Assaf
Publicado: (2021)

Characterization of novel monoclonal antibodies against the MERS-coronavirus spike protein and their application in species-independent antibody detection by competitive ELISA
por: Fukushi, Shuetsu, et al.
Publicado: (2018)

Potent binding of 2019 novel coronavirus spike protein by a SARS coronavirus-specific human monoclonal antibody
por: Tian, Xiaolong, et al.
Publicado: (2020)

Nanoparticle display of prefusion coronavirus spike elicits S1-focused cross-reactive antibody response against diverse coronavirus subgenera
por: Hutchinson, Geoffrey B., et al.
Publicado: (2023)

Antibodies to SARS Coronavirus in Civets
por: Tu, Changchun, et al.
Publicado: (2004)

Development and comparison of enzyme-linked immunosorbent assays based on recombinant trimeric full-length and truncated spike proteins for detecting antibodies against porcine epidemic diarrhea virus
por: Chang, Chia-Yu, et al.
Publicado: (2019)

Chicken antibodies against venom proteins of Trimeresurus stejnegeri in Taiwan
por: Lee, Chi-Hsin, et al.
Publicado: (2020)

The structure of a novel antibody against the spike protein inhibits Middle East respiratory syndrome coronavirus infections
por: Jang, Tae-Ho, et al.
Publicado: (2022)

Prepare for the Future: Dissecting the Spike to Seek Broadly Neutralizing Antibodies and Universal Vaccine for Pandemic Coronaviruses
por: Vangelista, Luca, et al.
Publicado: (2020)

Patient Perspectives on Anti-spike Monoclonal Antibody Therapy for Mild to Moderate Coronavirus Disease-2019
por: Razonable, Raymund R, et al.
Publicado: (2022)

Perspectives on Assembling Coronavirus Spikes on Fiber Optics to Reveal Broadly Recognizing Antibodies and Generate a Universal Coronavirus Detector
por: Sypabekova, Marzhan, et al.
Publicado: (2021)

SARS-CoV-2 spike S2-specific neutralizing antibodies
por: Li, Chia-Jung, et al.
Publicado: (2023)

COVID-19 vaccination recruits and matures cross-reactive antibodies to conserved epitopes in endemic coronavirus Spike proteins
por: Elko, Evan A, et al.
Publicado: (2022)

Long-Term Persistence of Spike Protein Antibody and Predictive Modeling of Antibody Dynamics After Infection With Severe Acute Respiratory Syndrome Coronavirus 2
por: Grandjean, Louis, et al.
Publicado: (2021)

Sensitive detection of total anti-Spike antibodies and isotype switching in asymptomatic and symptomatic individuals with COVID-19
por: Goh, Yun Shan, et al.
Publicado: (2021)

Identification of Neutralizing Monoclonal Antibodies Targeting Novel Conformational Epitopes of the Porcine Epidemic Diarrhoea Virus Spike Protein
por: Chang, Chia-Yu, et al.
Publicado: (2019)

Identification of severe acute respiratory syndrome coronavirus 2 breakthrough infections by anti-nucleocapsid antibody among fully vaccinated non-healthcare workers during the transition from the delta to omicron wave
por: Dai, Yu-Ching, et al.
Publicado: (2022)

Development and evaluation of an enzyme-linked immunosorbent assay for detection of antibodies against the spike protein of SARS-coronavirus
por: Zhao, Jincun, et al.
Publicado: (2005)

A conserved immunogenic and vulnerable site on the coronavirus spike protein delineated by cross-reactive monoclonal antibodies
por: Wang, Chunyan, et al.
Publicado: (2021)

Prevalence of severe acute respiratory syndrome coronavirus 2 spike antibodies in some healthcare settings in Egypt
por: El-Ghitany, Engy Mohamed, et al.
Publicado: (2022)

Deep repertoire mining uncovers ultra-broad coronavirus neutralizing antibodies targeting multiple spike epitopes
por: Hurtado, Jonathan, et al.
Publicado: (2023)

Orthobunyavirus spike architecture and recognition by neutralizing antibodies
por: Hellert, Jan, et al.
Publicado: (2019)

Coronaviruses pandemics: Can neutralizing antibodies help?
por: Tong, Phuoc-Bao-Viet, et al.
Publicado: (2020)

COVID-19 vaccination elicits an evolving, cross-reactive antibody response to epitopes conserved with endemic coronavirus spike proteins
por: Elko, Evan A., et al.
Publicado: (2022)

Neutralizing Antibody Response and SARS Severity
por: Ho, Mei-Shang, et al.
Publicado: (2005)

Cannot write session to /tmp/vufind_sessions/sess_ugjj0k6ks49e0fenl94sel0tqt